Chang J-B, Chen Y-L, Hung Y-J, Hsieh C-H, Lee C-H, Pei D, Lin J-D, Wu C-Z, Liang Y-J, Lin C-M
Chien-Ming Lin, MD, Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center; No. 325, Cheng-Kung Road, Section 2, Neihu 114, Taipei, Taiwan, R.O.C. E-mail:
J Nutr Health Aging. 2017;21(3):329-335. doi: 10.1007/s12603-016-0749-3.
Although it is known that high uric acid (UA) level is associated with type 2 diabetes (T2DM) and metabolic syndrome (MetS), most of the previous studies were focused on adults. Since aging becomes a major problem for many societies, in this longitudinal study, we investigated the role of UA in future T2DM and MetS in a large cohort of people who were older than 65 years.
A cross-sectional and longitudinal study.
SETTING/PARTICIPANTS: 18,907 elderly (9,732 men, 9,175 women) aged above 65 years, enrolled from health check-up centers, were classified into three subgroups by 10-year intervals (young old 65-74 years, YO; old old 75-84 years, OO; and oldest old 85-94 years, ODO), with the average follow-up period of 4.3 years.
The optimal cut-off values (CoVs) of baseline UA to predict future MetS and T2DM were determined by receiving operating characteristic (ROC) curve analysis. Using these CoVs of UA, the participants were divided into normal- and high-level groups of UA. Cox proportional hazard analysis was used to calculate hazard ratios (HRs) for the subjects with a high level of UA for the risk of future MetS and T2DM. In addition, Kaplan-Meier plots and log rank test were used to evaluate the time effect on the incidence of developing MetS and T2DM between the two groups.
In ROC curve analysis, the optimal CoVs of baseline UA were 6.0, 6.3 and 6.7 mg/dl in YO, OO, and ODO men, respectively; 5.5 and 4.9 mg/dl in YO and OO women, respectively (all p < 0.05). However, the CoVs of UA in ODO women (6.1 mg/dl) failed to show its discriminant power (p = 0.13). The Cox regression analysis showed the YO subjects with a higher baseline level of UA had a higher risk of developing MetS (HRs 1.56 and 1.58 for men and women, respectively, both p < 0.001); as for T2DM the HRs were 1.39 and 1.57. In OO men, the HRs was 1.89 for developing future MetS. However, no significant findings could be noted in the ODO group. Kaplan-Meier plots and log rank test also showed the same findings.
Our study showed that old subjects with high levels of UA will have a higher chance to have MetS and T2DM, particularly in the YO group (6.0 mg/dl for men and 5.5 mg/dl for women, respectively). Using UA as one of the metabolic biomarkers may help clinicians to early detect and prevent MetS and diabetes.
尽管已知高尿酸(UA)水平与2型糖尿病(T2DM)和代谢综合征(MetS)相关,但先前的大多数研究都集中在成年人身上。由于老龄化成为许多社会的一个主要问题,在这项纵向研究中,我们调查了UA在65岁以上的一大群人中未来发生T2DM和MetS的作用。
一项横断面和纵向研究。
设置/参与者:从健康体检中心招募的18907名65岁以上的老年人(9732名男性,9175名女性),按10年间隔分为三个亚组(年轻老年人65 - 74岁,YO;老年老年人75 - 84岁,OO;最老年老年人85 - 94岁,ODO),平均随访期为4.3年。
通过接受操作特征(ROC)曲线分析确定预测未来MetS和T2DM的基线UA的最佳截断值(CoV)。使用这些UA的CoV,将参与者分为UA正常水平组和高水平组。采用Cox比例风险分析计算UA高水平受试者未来发生MetS和T2DM风险的风险比(HR)。此外,使用Kaplan - Meier图和对数秩检验评估两组之间MetS和T2DM发病时间效应。
在ROC曲线分析中,YO组、OO组和ODO组男性的基线UA最佳CoV分别为6.0、6.3和6.7mg/dl;YO组和OO组女性分别为5.5和4.9mg/dl(均p < 0.05)。然而,ODO组女性的UA的CoV(6.1mg/dl)未显示出其判别能力(p = 0.13)。Cox回归分析显示,基线UA水平较高的YO受试者发生MetS的风险较高(男性和女性的HR分别为1.56和1.58,均p < 0.001);对于T2DM,HR分别为1.39和1.57。在OO组男性中,未来发生MetS的HR为1.89。然而,在ODO组中未发现显著结果。Kaplan - Meier图和对数秩检验也显示了相同的结果。
我们的研究表明,UA水平高的老年受试者患MetS和T2DM的机会更高,特别是在YO组(男性分别为6.0mg/dl,女性为5.5mg/dl)。将UA用作代谢生物标志物之一可能有助于临床医生早期检测和预防MetS和糖尿病。